雷多塔维:通过在小环中设置超环门,改善了血液动力学
Alok D Shah1, Anwar Hussain1, Andrew Wiper1
1Blackpool Teaching Hospitals NHS FT, Blackpool, United Kingdom.
JACC. Case reports
|December 17, 2025
概括
在患有小本土 annuli 的患者中,重新穿透导管大动脉植入 (TAVI) 提出了挑战. 在这些复杂的重复TAVI病例中,Allegra透管心脏 (THV) 提供了优势.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 医疗器械 医疗器械
背景情况:
- 过导管大动脉植入 (TAVI) 指示正在扩展到患有严重大动脉狭窄的年轻患者.
- 患者生存率的增加导致Redo TAVI手术的增加.
- 在Redo TAVI中,小型本土年树构成了重大挑战.
研究的目的:
- 描述一个早期透气管心脏 (THV) 衰竭的病例.
- 为突出重复TAVI的规划和流程,在一个小环的患者.
- 在重复TAVI场景中评估AllegraTHV的使用情况.
主要方法:
- 一个病例介绍,一个患有早期THV衰竭的患者接受重复TAVI.
- 重点重复TAVI的规划概念和流程.
- 利用计算机断层扫描 (CT) 分析用于程序规划.
主要成果:
- 阿莱格拉THV在一个小圆环中显示出更高的有效孔面积.
- 灵活的外流设计减少了传单压力.
- 精细的CT分析对于程序和血液动力学成功至关重要.
结论:
- 阿莱格拉THV是重复TAVI的可行选择,用于小环形患者.
- 先进的CT分析和专门的工具 (Redo TAVI应用程序) 对于成功重复TAVI至关重要.
- 精心规划和设备选择对于管理复杂的重复TAVI病例至关重要.
相关概念视频
Aortic Regurgitation III: Medical Management
373
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
373
Mitral Regurgitation III: Medical Management
253
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
253


